Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Ian McNiece"'
Autor:
Dileep R Yavagal, Baowan Lin, Ami P Raval, Philip S Garza, Chuanhui Dong, Weizhao Zhao, Erika B Rangel, Ian McNiece, Tatjana Rundek, Ralph L Sacco, Miguel Perez-Pinzon, Joshua M Hare
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e93735 (2014)
Intra-arterial (IA) delivery of mesenchymal stem cells (MSCs) for acute ischemic stroke is attractive for clinical translation. However, studies using rat model of stroke have demonstrated that IA MSCs delivery can decrease middle cerebral artery (MC
Externí odkaz:
https://doaj.org/article/aa4888015b4a4ff6b110e9e41afb9e26
Autor:
Joseph P. McGuirk, Ran Reshef, Michael R. Grunwald, Mary Eapen, Natasha Kekre, Rizwan Romee, Ephraim J. Fuchs, Christopher G. Kanakry, Mahasweta Gooptu, Robert J. Soiffer, Claudio G. Brunstein, Nilanjan Ghosh, Mark A. Schroeder, Saurabh Chhabra, Yoshihiro Inamoto, Ian McNiece, Filippo Milano, Dipenkumar Modi, Rohtesh S. Mehta, Monzr M. Al Malki, Joseph H. Antin, Edmund K. Waller, Marco Mielcarek, Andrew St. Martin, Christopher Bredeson, Scott R. Solomon, Mukta Arora
Publikováno v:
Blood
Post transplant cyclophosphamide (PTCy) graft-versus-host disease (GVHD) prophylaxis has allowed haploidentical (Haplo) transplantation to be performed with results similar to that after matched unrelated donor (MUD) transplantation with traditional
Autor:
Ian McNiece, Linda Kelley
Publikováno v:
Stem Cell Therapy for Autoimmune Disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::980c03a5d3f756e4bfb76f479f981ae8
https://doi.org/10.1201/9780367813895-12
https://doi.org/10.1201/9780367813895-12
Autor:
Monzr M. Al Malki, Nirav N. Shah, Vanderson Rocha, Karen K. Ballen, Rizwan Romee, Joseph P. McGuirk, John R. Wingard, Asad Bashey, Peiman Hematti, Mei-Jie Zhang, Richard E. Champlin, Sumithira Vasu, Stefan O. Ciurea, Ian McNiece, Javier Bolanos Meade, Andrew St. Martin, Sagar S. Patel, Zachariah DeFilipp, Nelli Bejanyan, Edmund K. Waller, Scott R. Solomon, Claudio G. Brunstein, Mehdi Hamadani, Mary Eapen, Marcelo C. Pasquini, Giancarlo Fatobene, Ephraim J. Fuchs, Christopher G. Kanakry
In the absence of prospective studies that examine the effect of conditioning regimen intensity after T-cell–replete haploidentical transplant for acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplastic syndrome (MDS),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fed94b735faf572492b4c12f5e7e502
https://europepmc.org/articles/PMC6784523/
https://europepmc.org/articles/PMC6784523/
Publikováno v:
Leukemia Research. 40:54-59
Leukemic cell lines have become important tools for studies of disease providing a monoclonal cell population that can be extensively expanded in vitro while preserving leukemic cellular characteristics. However, studies of chronic lymphocytic leukem
Publikováno v:
Cytotherapy. 17:1514-1523
Background aims Mesenchymal stromal cells (MSCs), derived from several tissues including bone marrow and adipose tissue, are being evaluated in clinical trials for a range of diseases. Virtually all tissues of the body contain stromal cells, yet it i
Autor:
Didier Blaise, Mary Eapen, Mohamad Mohty, Mei-Jie Zhang, Rizwan Romee, Tara M. Robinson, Jean-Henri Bourhis, Ibrahim Yakoub-Agha, Stefan O. Ciurea, Ephraim J. Fuchs, Asad Bashey, Shannon R. McCurdy, Robert J. Soiffer, Myriam Labopin, Fabio Ciceri, Vanderson Rocha, Arnon Nagler, Ian McNiece, Steven M. Devine, Andrew St. Martin, Noel Milpied, Gérard Socié, Daniel A. Keesler
We sought to identify whether posttransplantation cyclophosphamide (PT-Cy) reduces or eliminates the detrimental impact of HLA mismatching on outcomes of HLA-haploidentical related donor transplantation for acute leukemia. Data from 2143 donor-recipi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36622a0d467b47fb317710647f0ec24f
Autor:
Karen K. Ballen, Mary Eapen, Stefan O. Ciurea, Giancarlo Fatobene, Vanderson Rocha, Nirav N. Shah, Sagar S. Patel, Andrew St. Martin, Joseph P. McGuirk, Monzr M. Al Malki, Mei-Jie Zhang, Rizwan Romee, Mehdi Hamadani, Ian McNiece, Javier Bolaños-Meade, Nelli Bejanyan, Claudio G. Brunstein, Asad Bashey, Marcelo C. Pasquini, Richard E. Champlin, Sumithira Vasu, Ephraim J. Fuchs, John R. Wingard, Christopher G. Kanakry, Peiman Hematti, Zachariah DeFilipp, Edmund K. Waller, Scott R. Solomon
Publikováno v:
Blood. 132:1015-1015
The significance of conditioning regimen intensity on the outcomes of T-cell replete HLA-haploidentical transplants is not known. This study compared outcomes of commonly used myeloablative (MAC) to reduced intensity (RIC) conditioning regimens in 13
Autor:
Dorothy Hehre, Claudia O. Rodrigues, Jammie Klim, Eneida Torres, Cleide Suguihara, Jian Huang, Joshua M. Hare, Shalini Ramachandran, Karen C. Young, Ian McNiece, Luis F. Miranda
Publikováno v:
Pediatric Research. 74:682-688
Stem cell factor (SCF) and its receptor, c-kit, are modulators of angiogenesis. Neonatal hyperoxia-induced lung injury (HILI) is characterized by disordered angiogenesis. The objective of this study was to determine whether exogenous SCF improves rec
Autor:
Myra Rodriguez, Dorothy Hehre, Ronald P. Sutsko, Cleide Suguihara, Ana Ribeiro, Ian McNiece, Karen C. Young, Carlos Devia, Eneida Torres
Publikováno v:
Pediatric Research. 73:46-53
Mesenchymal stem cell (MSC) therapy may prevent neonatal hyperoxia-induced lung injury (HILI). There are, however, no clear data on the therapeutic efficacy of MSC therapy in established HILI, the duration of the reparative effects, and the exact mec